Evotec buys custom cells and reagents supplier

01/4/2013 | Genetic Engineering & Biotechnology News

Cell Culture Service, a supplier of custom cells and cell-based reagents, has been acquired by Evotec for $1.5 million upfront plus as much as $1.4 million in milestone fees. Evotec said the deal would improve its ability to offer integrated drug discovery and early development services for drugmakers. "CCS' experience and technologies for large-scale cell production are a perfect fit with Evotec's screening and in vitro pharmacology activities," Evotec COO Mario Polywka said.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Abbott
Santa Clara, CA
Director, Site Quality Management
CareFusion
Minneapolis, MN